Assessing the Benefit-Risk Profile for Pediatric Implantable Auditory Prostheses

Area of Science:

• Otolaryngology
• Biomedical Engineering
• Pediatric Audiology

Background:

• Children with congenital cochleovestibular abnormalities and profound hearing loss have limited treatment options.
• Cochlear implantation may not benefit all children, necessitating alternative solutions like the auditory brainstem implant (ABI).
• A structured benefit-risk assessment for ABI, crucial for regulatory approval and clinical guidance, has been lacking.

Purpose of the Study:

• To apply a structured benefit-risk assessment framework, adapted from drug trials, to auditory brainstem implant (ABI) device studies.
• To guide the selection of pediatric candidates for ABI by organizing information on speech recognition, parent-reported outcomes, and surgical/device risks.
• To inform the design of a research program incorporating input from regulatory authorities, families, and healthcare professionals.

Main Methods:

• Utilized a qualitative framework to systematically evaluate benefits (e.g., speech recognition, parent reports) and risks (surgical, device-related) for ABI candidacy.
• Adapted structured benefit-risk assessment methodologies commonly used in pharmaceutical trials for application to medical device studies.
• Focused on children with cochleovestibular anatomical abnormalities, who present unique challenges in assessing candidacy for cochlear implants or ABIs.

Main Results:

• Preliminary findings suggest that children receiving an ABI experience gradual auditory benefit over time.
• Assessing candidacy for cochlear implants or ABIs in children with cochleovestibular abnormalities is complex.
• A multidisciplinary team approach, including audiological, occupational, and educational therapy, maximizes the potential benefit from ABI.

Conclusions:

• Pediatric patients with abnormal anatomy considered for implantable auditory prosthetics require a comprehensive, individualized assessment.
• The qualitative benefit-risk assessment highlighted the intricate factors involved, including medical need, potential benefits, and risk management.
• Sustained family support and intensive post-implantation therapy are essential for optimizing auditory skill development and maximizing benefits from ABI.